
Compass Therapeutics, Inc.
USD2.23
+0.07 (+3.47%)
CEO
Thomas J. Schuetz
IPO Date
2021-04-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.16
Prev. Close
$2.16
Day Low
$2.13
Day High
$2.24
52W Low
$1.61
52W High
$6.88
Market Cap
$0.31B
Volume
0.98M
| 27 Apr 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 24 Mar 2026 | Guggenheim | Buy | Buy | maintain |
| 6 Jan 2026 | D. Boral Capital | Buy | Buy | maintain |
| 5 Nov 2025 | D. Boral Capital | Buy | Buy | maintain |
| 12 Aug 2025 | Guggenheim | Buy | Buy | maintain |
| 12 Aug 2025 | D. Boral Capital | Buy | Buy | maintain |
| 9 May 2025 | Guggenheim | Buy | Buy | maintain |